High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
Daniel R. Carrasco(Brigham and Women's Hospital), Giovanni Tonon(Dana-Farber Cancer Institute), Yongsheng Huang(University of Arkansas for Medical Sciences), Yunyu Zhang(Dana-Farber Cancer Institute), Raktim Sinha(Dana-Farber Cancer Institute), Bin Feng(Dana-Farber Cancer Institute), Peter Stewart(University of Arkansas for Medical Sciences), Fenghuang Zhan(University of Arkansas for Medical Sciences), Deepak Khatry(Dana-Farber Cancer Institute), Marina Protopopova(Dana-Farber Cancer Institute), Alexei Protopopov(Dana-Farber Cancer Institute), Kumar Sukhdeo(Dana-Farber Cancer Institute), Ichiro Hanamura(University of Arkansas for Medical Sciences), Owen Stephens(University of Arkansas for Medical Sciences), Bart Barlogie(University of Arkansas for Medical Sciences), Kenneth C. Anderson(Dana-Farber Cancer Institute), Lynda Chin(Brigham and Women's Hospital), John D. Shaughnessy(University of Arkansas for Medical Sciences), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Ronald A. DePinho(Dana-Farber Cancer Institute)
Cited by 425Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis